// App-Quantinova.ai

: PLASMA LEVELS AND OUTCOMES OF PROPHYLACTIC POST-TRANSPLANT PONATINIB ADMINISTRATION IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)

Researchers

Presenter

  • Satoru Nanno

Principal Investigators

  • Hiroshi Okamura

  • Mika Nakamae

  • Asao Hirose

  • Kana Matsumoto

  • Kunihiko Morita

  • Yasuhiro Nakashima

  • Hideo Koh

  • Takahiko Nakane

  • Masayuki Hino

  • Hirohisa Nakamae

Medical Centers

  • Hematology, Graduate School of Medicine, Osaka City University,

  • Department of clinical pharmaceutics, Faculty of pharmaceutical sciences,Doshisha Women's College of Liberal Arts,Kyoto,Giappone

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Ponatinib

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved